Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jan 2;24(1):3.
doi: 10.1186/s12933-024-02564-w.

Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes

Affiliations
Comparative Study

Deep-learning prediction of cardiovascular outcomes from routine retinal images in individuals with type 2 diabetes

Mohammad Ghouse Syed et al. Cardiovasc Diabetol. .

Abstract

Background: Prior studies have demonstrated an association between retinal vascular features and cardiovascular disease (CVD), however most studies have only evaluated a few simple parameters at a time. Our aim was to determine whether a deep-learning artificial intelligence (AI) model could be used to predict CVD outcomes from routinely obtained diabetic retinal screening photographs and to compare its performance to a traditional clinical CVD risk score.

Methods: We included 6127 individuals with type 2 diabetes without myocardial infarction or stroke prior to study entry. The cohort was divided into training (70%), validation (10%) and testing (20%) cohorts. Clinical 10-year CVD risk was calculated using the pooled cohort equation (PCE) risk score. A polygenic risk score (PRS) for coronary heart disease was also obtained. Retinal images were analysed using an EfficientNet-B2 network to predict 10-year CVD risk. The primary outcome was time to first major adverse CV event (MACE) including CV death, myocardial infarction or stroke.

Results: 1241 individuals were included in the test cohort (mean PCE 10-year CVD risk 35%). There was a strong correlation between retinal predicted CVD risk and the PCE risk score (r = 0.66) but not the polygenic risk score (r = 0.05). There were 288 MACE events. Higher retina-predicted risk was significantly associated with increased 10-year risk of MACE (HR 1.05 per 1% increase; 95% CI 1.04-1.06, p < 0.001) and remained so after adjustment for the PCE and polygenic risk score (HR 1.03; 95% CI 1.02-1.04, p < 0.001). The retinal risk score had similar performance to the PCE (both AUC 0.697) and when combined with the PCE and polygenic risk score had significantly improved performance compared to the PCE alone (AUC 0.728). An increase in retinal-predicted risk within 3 years was associated with subsequent increased MACE likelihood.

Conclusions: A deep-learning AI model could accurately predict MACE from routine retinal screening photographs with a comparable performance to traditional clinical risk assessment in a diabetic cohort. Combining the AI-derived retinal risk prediction with a coronary heart disease polygenic risk score improved risk prediction. AI retinal assessment might allow a one-stop CVD risk assessment at routine retinal screening.

Keywords: Artificial intelligence; Cardiovascular risk; Diabetes; Retina.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Data analysis was conducted within the Health Informatics Centre Trusted Research Environment under its overarching ethics approval for approved researchers to conduct research within their secure environment (East of Scotland Research Ethics Committee reference: 18/ES/0126). As the study data are de-identified, consent from individual patients was not required. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Example of pre-processing result (top) and Average of Grad-CAM heatmaps for PCE risk score prediction superimposed on a sample left eye and right eye retina (bottom). A Original retinal image; B pre-processed image; C heatmap for left eye retinas; D heatmap for right eye retinas
Fig. 2
Fig. 2
Correlations between individual-level retinal predicted 10-year MACE, clinical CVD risk and genetic CHD risk. A Predicted 10-year MACE vs. CHD PRS. B Predicted 10-year MACE vs. PCE risk score. Red dots represent females and blue dots represent males
Fig. 3
Fig. 3
Major adverse cardiovascular events stratified by retinal predicted CVD risk. Kaplan-Meier curves showing MACE-free survival at 10 years stratified by tertiles of retinal predicted CVD risk derived from individual-level prediction at baseline
Fig. 4
Fig. 4
Major Adverse Cardiovascular Events Based on Progression of Retinal Predicted CVD Risk

References

    1. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus—mechanisms, management, and clinical considerations. Circulation. 2016;133:2459–502. - PMC - PubMed
    1. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29–36. - PubMed
    1. American Diabetes Association Professional Practice C. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S144-S174. - PubMed
    1. McGuire DK, Shih WJ, Cosentino F, Charbonnel B, Cherney DZI, Dagogo-Jack S, Pratley R, Greenberg M, Wang S, Huyck S, Gantz I, Terra SG, Masiukiewicz U, Cannon CP. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. JAMA Cardiol. 2021;6:148–58. - PMC - PubMed
    1. Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, Lam CSP, Lopes RD, McMurray JJV, Pratley RE, Rosenstock J, Gerstein HC. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9:653–62. - PubMed

MeSH terms

LinkOut - more resources